A2 Biotherapeutics

Agoura Hills, United States

A2 Biotherapeutics develops T cell therapies targeting solid tumors precisely.

May 2025

Grant

Biotechnology Health Care Life Science

Top Investors

Samsara BioCapitalThe Column GroupVida VenturesCasdin CapitalNextech Invest

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about A2 Biotherapeutics

Who are A2 Biotherapeutics's investors?

A2 Biotherapeutics's investors include Samsara BioCapital, The Column Group, Vida Ventures, Casdin Capital, Nextech Invest.

Where is A2 Biotherapeutics headquartered?

A2 Biotherapeutics is headquartered in Agoura Hills, United States.

What does A2 Biotherapeutics do?

A2 Biotherapeutics develops T cell therapies targeting solid tumors precisely.

What stage is A2 Biotherapeutics at?

A2 Biotherapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 6, 2025.

MLA

"A2 Biotherapeutics — Funding & Investors." VCBacked, May 6, 2025, https://www.vcbacked.co/company/a2-biotherapeutics. Accessed July 1, 2026.

APA

VCBacked. (2025). A2 Biotherapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/a2-biotherapeutics

Wikipedia (cite web)

{{cite web |title=A2 Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/a2-biotherapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 6, 2025.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.